文献速递腹部CT

双能CT细胞外容积分数评估肝纤维化作为持续病毒学应答后肝细胞癌风险因素:初步病例对照研究

Liver fibrosis estimated using extracellular volume fraction obtained from dual-energy CT as a risk factor for hepatocellular carcinoma after sustained virologic response: A preliminary case-control study.
PubMed 文献 · Eur J Radiol · 2023-09-27

该研究纳入92例丙型肝炎病毒感染后持续病毒学应答患者,采用双能CT平衡期计算细胞外容积分数(ECV)。肝细胞癌组ECV为26.1±4.6%,无肝细胞癌组为20.7±3.3%(p<0.001);ECV诊断肝细胞癌的截断值为24.3%,AUC为0.857。多因素分析显示ECV是唯一与肝细胞癌独立相关的因素(OR 0.619,95%CI 0.482-0.795,p<0.001)。

要点

  • 持续病毒学应答后肝细胞癌组ECV 26.1±4.6%,无肝细胞癌组20.7±3.3%,组间差异显著(p<0.001)。
  • ECV诊断肝细胞癌截断值24.3%,AUC 0.857,高于血清纤维化标志物。
  • 多因素分析中ECV是唯一与肝细胞癌独立相关的因素(OR 0.619,95%CI 0.482-0.795,p<0.001)。

核心结论

  • 使用双能CT获得的细胞外容积分数评估肝纤维化,可作为持续病毒学应答后肝细胞癌的预测标志物。

研究设计与样本

  • 初步病例对照研究,纳入92例丙型肝炎病毒感染后持续病毒学应答患者(男52例、女40例,平均年龄69.9岁),于2020年1月至2022年3月行肝脏双能CT检查(3分钟平衡期图像),通过碘密度测量计算ECV。

关键影像表现/征象

  • 肝细胞癌组(n=21)ECV为26.1±4.6%,无肝细胞癌组(n=71)ECV为20.7±3.3%,肝细胞癌组显著大于无肝细胞癌组(p<0.001)。

诊断标准与关键数值

  • ECV诊断肝细胞癌的截断值为24.3%。
  • ECV诊断肝细胞癌的ROC曲线下面积为0.857,高于血清纤维化标志物。
  • 单因素分析显示高龄、干扰素治疗获得持续病毒学应答、甲胎蛋白>5 ng/mL、治疗前晚期纤维化(>F3)及ECV与肝细胞癌相关。
  • 多因素分析显示ECV是唯一与肝细胞癌独立相关的因素(OR 0.619,95%CI 0.482-0.795,p<0.001)。

临床应用与阅片要点

  • ECV可作为持续病毒学应答后肝细胞癌风险的预测指标,截断值24.3%可供阅片时参考。
  • ECV诊断肝细胞癌的AUC为0.857,高于血清纤维化标志物。
  • 多因素分析中ECV是唯一独立相关因素,提示其在风险分层中的潜在价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess hepatocellular carcinoma (HCC) risk after sustained virologic response (SVR) through clinical data analyses, including evaluation of liver fibrosis using the extracellular volume fraction (ECV) obtained from dual-energy computed tomography (DECT).

METHODS: Ninety-two patients (52 men and 40 women; mean age, 69.9 years) with hepatitis C virus infection after SVR underwent DECT of the liver (3-minute equilibrium-phase images) between January 2020 and March 2022. The ECV was calculated by measuring iodine density; fibrous markers, including ECV, fibrosis-4 index, aspartate aminotransferase to platelet ratio index, and platelet count, were statistically analyzed (p < 0.05). The risk factors associated with HCC were analyzed using univariate and multivariate logistic regression analyses.

RESULTS: The ECV (26.1 ± 4.6 %) in patients with HCC (n,21) was significantly larger than the ECV (20.7 ± 3.3 %) in patients without HCC (n = 71) (p < 0.001). The cutoff value for the ECV was 24.3 %. The area under the operating characteristic curve of the ECV was 0.857, which was higher than that of the serum fibrosis markers. Older age, SVR achieved with interferon, alpha-fetoprotein level (>5 ng/mL), advanced fibrosis before treatment (>F3), and ECV were associated with HCC according to the univariate analysis. Multivariate analyses showed that ECV was the only factor independently associated with HCC (odds ratio 0.619, 95 % confidence interval 0.482-0.795, p < 0.001).

CONCLUSION: Liver fibrosis estimated using ECV can be a predictive marker in patients with HCC after SVR.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Ozaki K, Ohtani T, Ishida T, et al. Liver fibrosis estimated using extracellular volume fraction obtained from dual-energy CT as a risk factor for hepatocellular carcinoma after sustained virologic response: A preliminary case-control study. Eur J Radiol. 2023. PMID: 37783146. doi:10.1016/j.ejrad.2023.111112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。